These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2485125)

  • 1. Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera.
    Heidenreich F; Vincent A; Roberts A; Newsom-Davis J
    Autoimmunity; 1988; 1(4):285-97. PubMed ID: 2485125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis.
    Lennon VA; Griesmann GE
    Neurology; 1989 Aug; 39(8):1069-76. PubMed ID: 2474772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
    Tzartos SJ; Sophianos D; Efthimiadis A
    J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
    Whiting PJ; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies that distinguish between normal and denervated human acetylcholine receptor.
    Whiting PJ; Vincent A; Schluep M; Newsom-Davis J
    J Neuroimmunol; 1986 May; 11(3):223-35. PubMed ID: 3082932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
    Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G
    Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
    Loutrari H; Kokla A; Trakas N; Tzartos SJ
    Clin Exp Immunol; 1997 Sep; 109(3):538-46. PubMed ID: 9328134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibodies directed against the cytoplasmic region of the human acetylcholine receptor in sera from myasthenia gravis patients.
    Tzartos SJ; Remoundos M
    Clin Exp Immunol; 1999 Apr; 116(1):146-52. PubMed ID: 10209519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S; LeBoeuf RD; Blalock JE
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8747-51. PubMed ID: 8378359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
    Graus YF; de Baets MH; Parren PW; Berrih-Aknin S; Wokke J; van Breda Vriesman PJ; Burton DR
    J Immunol; 1997 Feb; 158(4):1919-29. PubMed ID: 9029134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal anti-acetylcholine receptor antibodies as probes for human acetylcholine-receptor in myasthenia gravis.
    Vincent A; Whiting PJ; Heidenreich F; Roberts A
    J Recept Res; 1988; 8(1-4):143-59. PubMed ID: 3260283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera.
    Sophianos D; Tzartos SJ
    J Autoimmun; 1989 Dec; 2(6):777-89. PubMed ID: 2619869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
    Vernet-der Garabedian B; Morel E; Bach JF
    J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of conformationally dependent epitopes on the N-terminal extracellular domain of the human muscle acetylcholine receptor alpha subunit expressed in Escherichia coli: implications for myasthenia gravis therapeutic approaches.
    Tsouloufis T; Mamalaki A; Remoundos M; Tzartos SJ
    Int Immunol; 2000 Sep; 12(9):1255-65. PubMed ID: 10967020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to acetylcholine receptor in canine and human myasthenia gravis: differential cross-reactivity with human and rabbit receptor.
    Dau PC; Yano CS; Ettinger SJ
    Neurology; 1979 Jul; 29(7):1065-8. PubMed ID: 572937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis.
    Hara H; Hayashi K; Ohta K; Itoh N; Nishitani H; Ohta M
    Clin Chem; 1993 Oct; 39(10):2053-7. PubMed ID: 8403390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera.
    Loutrari H; Tzartos SJ; Claudio T
    Eur J Immunol; 1992 Nov; 22(11):2949-56. PubMed ID: 1385157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.